Evidence map›Paper›PMID 30263905›Full record

ArticleBio-protocol2018

Cell Synchronization by Double Thymidine Block.

Guo Chen, Xingming Deng

Open access · greenAbstract read
In one paragraph

Article in Bio-protocol, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 179 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Guo ChenDepartment of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, USA.
Xingming DengDepartment of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, USA.
Winship Cancer Institute

Funding

Structure-based anti-cancer drug developmentR01CA136534 · NCI · EMORY UNIVERSITY · PI DENG, XINGMING · 2010 to 2020
$3.4M
Modulation of Bcl2 BH4 and mTOR in lung cancer therapeuticsR01CA193828 · NCI · EMORY UNIVERSITY · PI DENG, XINGMING · 2015 to 2019
$1.8M
Modulation of BAK in Lung Cancer TherapeuticsR01CA200905 · NCI · EMORY UNIVERSITY · PI DENG, XINGMING · 2017 to 2021
$1.8M
NCI NIH HHS R01 CA136534NCI NIH HHS R01 CA193828NCI NIH HHS R01 CA200905
6 · The paper itself

Abstract

Cell synchronization is widely used in studying mechanisms involves in regulation of cell cycle progression. Through synchronization, cells at distinct cell cycle stage could be obtained. Thymidine is a DNA synthesis inhibitor that can arrest cell at G1/S boundary, prior to DNA replication. Here, we present the protocol to synchronize cells at G1/S boundary by using double thymidine block. After release into normal medium, cell population at distinct cell cycle phase could be collected at different time points.

Indexed as

Cell cycleCell synchronizationDNA replicationDNA synthesisThymidine

Identifiers

PMID30263905
PMCPMC6156087
OpenAlexW2890395111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.